Northwestern Mutual Wealth Management
ZVRA icon

Northwestern Mutual Wealth Management’s Zevra Therapeutics ZVRA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Hold
15,000
– – ﹤0.01% 1974
2026
Q1 		$140K Hold
15,000
– – ﹤0.01% 2044
2025
Q4 		$134K Buy
+15,000
New +$142K ﹤0.01% 2017

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northwestern Mutual Wealth Management's ZVRA Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Zevra Therapeutics (ZVRA) position steady in Q2 2026 at 15,000 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #1974.

Northwestern Mutual Wealth Management first reported a position in ZVRA in Q4 2025 and has held it in 3 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Northwestern Mutual Wealth Management held 15,000 shares of Zevra Therapeutics worth $215K as of Q2 2026.
  • Northwestern Mutual Wealth Management left its Zevra Therapeutics share count unchanged in Q2 2026.
  • Zevra Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #1974 holding.
  • Northwestern Mutual Wealth Management first reported a position in Zevra Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.